TD Asset Management Inc Boosts Stock Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

TD Asset Management Inc lifted its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report) by 37.5% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 545,665 shares of the medical instruments supplier’s stock after purchasing an additional 148,788 shares during the quarter. TD Asset Management Inc owned 0.26% of DENTSPLY SIRONA worth $19,420,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. Parkside Financial Bank & Trust lifted its stake in shares of DENTSPLY SIRONA by 33.3% in the 4th quarter. Parkside Financial Bank & Trust now owns 1,169 shares of the medical instruments supplier’s stock valued at $42,000 after acquiring an additional 292 shares during the last quarter. Beach Investment Counsel Inc. PA raised its position in DENTSPLY SIRONA by 1.4% during the 4th quarter. Beach Investment Counsel Inc. PA now owns 22,125 shares of the medical instruments supplier’s stock valued at $787,000 after purchasing an additional 306 shares during the last quarter. VisionPoint Advisory Group LLC raised its position in DENTSPLY SIRONA by 104.2% during the 3rd quarter. VisionPoint Advisory Group LLC now owns 774 shares of the medical instruments supplier’s stock valued at $26,000 after purchasing an additional 395 shares during the last quarter. Treasurer of the State of North Carolina raised its position in DENTSPLY SIRONA by 0.5% during the 3rd quarter. Treasurer of the State of North Carolina now owns 92,842 shares of the medical instruments supplier’s stock valued at $3,171,000 after purchasing an additional 470 shares during the last quarter. Finally, UMB Bank n.a. raised its position in DENTSPLY SIRONA by 0.6% during the 4th quarter. UMB Bank n.a. now owns 74,181 shares of the medical instruments supplier’s stock valued at $2,640,000 after purchasing an additional 473 shares during the last quarter. Institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Trading Up 0.9 %

Shares of NASDAQ XRAY opened at $28.01 on Monday. The company has a current ratio of 1.43, a quick ratio of 0.97 and a debt-to-equity ratio of 0.54. The stock has a 50 day moving average price of $29.97 and a 200 day moving average price of $32.42. DENTSPLY SIRONA Inc. has a 52-week low of $26.27 and a 52-week high of $41.65.

DENTSPLY SIRONA (NASDAQ:XRAYGet Free Report) last posted its earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.42. The company had revenue of $953.00 million during the quarter, compared to analyst estimates of $969.45 million. DENTSPLY SIRONA had a positive return on equity of 11.54% and a negative net margin of 2.41%. DENTSPLY SIRONA’s revenue was down 2.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.39 earnings per share. As a group, equities analysts forecast that DENTSPLY SIRONA Inc. will post 2.03 EPS for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 12th. Stockholders of record on Friday, June 28th will be issued a dividend of $0.16 per share. The ex-dividend date is Friday, June 28th. This represents a $0.64 annualized dividend and a dividend yield of 2.28%. DENTSPLY SIRONA’s dividend payout ratio is presently -145.45%.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on XRAY. Evercore ISI decreased their target price on DENTSPLY SIRONA from $40.00 to $35.00 and set an “outperform” rating for the company in a research report on Friday, May 3rd. Barrington Research dropped their price target on DENTSPLY SIRONA from $41.00 to $38.00 and set an “outperform” rating on the stock in a research note on Friday, May 3rd. StockNews.com downgraded DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Friday, May 3rd. Piper Sandler reaffirmed a “neutral” rating and issued a $32.00 target price (down from $35.00) on shares of DENTSPLY SIRONA in a report on Friday, May 3rd. Finally, SVB Leerink began coverage on DENTSPLY SIRONA in a research report on Monday, February 26th. They set an “outperform” rating and a $42.00 price objective for the company. Five equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $35.22.

Read Our Latest Analysis on XRAY

DENTSPLY SIRONA Profile

(Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Further Reading

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.